# OnCo record idea-acc-post-approval-evidence-over-75 (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-acc-post-approval-evidence-over-75/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-acc-post-approval-evidence-over-75" ;
  schema:name "Require post-approval evidence in patients over 75 and update labels accordingly"@en ;
  schema:description "New cancer drugs are approved on trials of younger, fitter patients, then given mostly to older ones. Regulators should require real-world safety and benefit data in the over-75s and put it on the label."@en ;
  schema:url <https://onco.cc/ideas/idea-acc-post-approval-evidence-over-75/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(21)01789-X> ;
  onco:terms <https://onco.cc/terms/real-world-evidence/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-aging-comorbidity/>, <https://onco.cc/bottlenecks/b-real-world-evidence/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .